|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Diagnosis and classification of myelodysplastic syndrome : International Working Group on Morphology of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myeloblasts and ring sideroblasts显示文摘 | Mufti GJ Bennett JM Goasguen J | 2008 | Haematologica2008，93，： | 1 |
| 2 | Successful pregnancies involving men with chronic myeloid leukaemia on imatinib therapy显示文摘 | Ramasamy KHJ Lim Z Mufti GJ | | 0，，04： | 1 |
| 3 | Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant显示文摘 | Shaw BE Mufti GJ Mackinnon S | | 0，，12： | 1 |
| 4 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase Ⅲ study 显示文摘 | Fenaux P Mufti GJ Hellstrom-Lindberg E | 2009 | Lancet Oncol2009，10，3： | 1 |
| 5 | Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromes 显示文摘 | Silverman LR Fenaux P Mufti GJ | 2011 | Cancer2011，117，12： | 1 |
| 6 | Role of4-1BB:4-1BB ligand in cancer immunotherapy 显示文摘 | Cheuk AT Mufti GJ Guinn BA | 2004 | Cancer Gene Ther2004，11，3： | 1 |
| 7 | Azaeitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloidleukemia显示文摘 | Fenaux P Mufti GJ Hellstrom-Lindberg E | 2010 | J Clin Oncol2010，28，4： | 1 |
| 8 | A muhieenter phase 2 study of the farnesyhransferase inhibitor tipifarnib in intermediate-to high-risk myelodys-plastic syndrome 显示文摘 | Fenaux P Raza A Mufti GJ | 2007 | Blood2007，109，： | 1 |
| 9 | Update on de,elop- ments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS) : consensus statements and report from an expert workshop 显示文摘 | Platzbecker U Santini V Mufti GJ | 2012 | Leuk Res2012，36，3： | 1 |
| 10 | Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphology of myelodysplastic syn drome (IWGM-MDS) consensus proposals for the defini tion and enumeration of myeloblasts and ring sideroblasts 显示文摘 | Mufti GJ Bennett JM Goasguen J etal | 2008 | Haematologica2008，93，11： | 1 |
| 11 | Diagnosis and classification of myelodysplastic syndrome: International Working Group on Morphlolgy of myelodysplastic syndrome (IWGM-MDS) consensus proposals for the definition and enumeration of myelohlasts and ring siderohlasts显示文摘 | Mufti GJ BennettJM GoasguenJ | 2008 | Haematologica2008，93，11： | 1 |
| 12 | Pathobiology, classification, and diagnosis of myelodysplastic syndrome显示文摘 | | 2004 | Best Pract Res Clin Haematol2004，17，4： | 1 |
| 13 | Applying synthetic lethality for the selective targeting of cancer显示文摘 | Mclornan DP List A Mufti GJ | 2014 | New Engl J Med2014，371，18： | 1 |
| 14 | Ineffective haemapoiesis and apoptosis in myelodysplastic syndromes 显示文摘 | Mufti GJ | 1998 | Br J Haematol1998，101，2： | 1 |
| 15 | A multicenter phase 2 study of the farnesyltransferase inhibitor tipifarnib in intermediate to high-risk myelodysplastic syndrome 显示文摘 | Fenaux P Raza A Mufti GJ | 2007 | Blood2007，109，10： | 1 |
| 16 | Efficacy of azacitidine compared with that of conventional care regi- mens in the treatment of higher - risk myelodysplastic syn- dromes : a randomised, open - label, phase III study 显示文摘 | Fenaux P Mufti GJ Hellstrom - Lindberg E | 2009 | Lancet Onco12009，10，3： | 1 |
| 17 | Evaluation of bone marrowreticulin formation in chronic immune thrombocytopenia patientstreated with romiplostim显示文摘 | Kuter DJ Mufti GJ Bain BJ | 2009 | Blood2009，114，18： | 1 |
| 18 | Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes:a randomised,open-label,phase III study显示文摘 | Fenaux P Mufti GJ Hellstrom-Lindberg E | | 0，，03： | 1 |
| 19 | Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia显示文摘 | Fenaux P Mufti GJ Hellstr?m-Lindberg E | | 0，，04： | 1 |
| 20 | Efficacy of Azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A ran- domised, open-label, phase ]II study显示文摘 | Fenaux P Mufti GJ Hellstrom-Lindterd E | 2009 | Lancet Oncol2009，10，3： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员